Primary drug resistance to anti-tuberculous drugs in Karachi.
OBJECTIVE
To assess the frequency of primary drug resistance among newly diagnosed tuberculosis cases in Karachi.


METHODS
Cross-sectional study.


METHODS
Multicentric study involving various TB clinics and treatment centres of Karachi between April to December 2005.


METHODS
The frequency of drug resistance among new TB patients was evaluated using a non-probability convenient sampling methodology. Sputum sample was obtained from 140 newly diagnosed sputum smear-positive patients of pulmonary tuberculosis from various centres of Karachi. Sensitivities were performed by proportion method.


RESULTS
Fifteen (11.5%) samples in 130 eligible patients showed primary resistance to one or more drugs. Ten (7.6%) of the isolates tested were resistant to a single drug, none were resistant to 2 drugs, 4 (3.0%) to 3 drugs and 1 (0.76%) to 4 drugs while 1 (0.76%) to all 5 first line agents. Resistance to streptomycin (10 microg/ml) was seen in 8 (6.1%), isoniazid (1microg/ml) in 12 (9.2%), Rifampicin (5 microg/ml) in 4 (3.0%), ethambutol (10 microg/ml) in 1 (0.76%) and pyrazinamide in 6 (4.6%) samples. Primary Multi-Drug Resistance (PMDR) was found in 2 (1.5%) patients. (Isoniazid 1 microg/ml, rifampicin 5 microg/ml with or without other drugs).


CONCLUSIONS
In the studied patients, primary drug resistance to at least one anti-tuberculosis drug was 11.5%. It requires an efficiently working anti-tuberculosis programme to prevent escalation including resistance.
Javaid
Arshad
A
Department of Pulmonology, Postgraduate Medical Institute, Peshawar. arshadj343@hotmail.com
Rizvi
Nadim
N
Ansari
Mosavir
M
Sadiq
Ashraf
A
Burki
Iqbal Sher
IS
Rehman
Nadeem Ur
NU
Hasan
Rumina
R
Zafar
Afia
A
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D004198:Disease Susceptibility; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010154:Pakistan; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents